Health
Novel CAR-T platform uses radiation-activated switch to destroy tumors more effectively
Medical Xpress·November 19, 2026

Engineering patients' own immune cells to find and destroy cancer using chimeric antigen receptor (CAR) T-cell therapy has transformed the treatment of blood cancers. However, its use is limited in solid tumors because the immunosuppressive tumor microenvironment prevents CAR T-cell entry into the tumor and causes cells that enter to become exhausted.
Read the full story at Medical Xpress →